Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Completed · Phase 4

Conditions studied: Hepatitis C, Human Immunodeficiency Virus, HIV Infections

In brief

This study is designed to test the hypothesis that treatment of hepatitis C virus (HCV) infection during the first 6 months after acquiring HCV among people who already have pre-existing HIV infection will result in improved responses to HCV therapy with a shorter duration of infection.

Key facts

Study ID

NCT00845676

Run by

University of California, San Francisco

People needed

21

Starts

2008-03-01

Expected to finish

2013-12-01

Last updated by the study team

2020-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly acquired HCV infection of 6 months or less duration
• Detectable HCV RNA at study entry
• HIV infection, any CD4 count

You may not qualify if…

• Pregnant or intent to become pregnant within 24 weeks of study completion
• Uncontrolled depression
• Other serious liver disease
• Other safety parameters must be met

Where it is running

• San Francisco General Hospital/UCSF — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.